Nonalcoholic Fatty Liver Disease (NAFLD) in Type 2 Diabetes Mellitus (T2DM) Patients in India: A Real-World Perspective

被引：0
|
作者：
Singh, Vikram Jit
Singh, Manmohan
Patidar, Hemant
机构：
来源：
DIABETES | 2020年 / 69卷
关键词：
D O I：
10.2337/db20-1506-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1506-P
引用
收藏
页数：2
相关论文
共 50 条
  • [41] GLYCATED HEMOGLOBIN (HBA1C) CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM) TREATED WITH CANAGLIFLOZIN IN A REAL-WORLD SETTING
    Lefebvre, P.
    Pilon, D.
    Robitaille, M.
    Lafeuille, M.
    Chow, W.
    Pfeifer, M.
    Duh, M. S.
    VALUE IN HEALTH, 2015, 18 (03) : A57 - A57
  • [42] Real-world 12-month outcomes of patients with type 2 diabetes mellitus (T2DM) treated with canagliflozin in a US managed care setting
    Chow, Wing
    Buysman, Erin
    Rupnow, Marcia
    Anderson, Amy
    Henk, Henry
    Fegade, Mayuresh
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S118 - S118
  • [43] Real-World 12-Month Outcomes of Patients with Type 2 Diabetes Mellitus (T2DM) Treated with Canagliflozin in a US Managed Care Setting
    Chow, Wing
    Buysman, Erin K.
    Rupnow, Marcia F. T.
    Anderson, Amy J.
    Henk, Henry J.
    DIABETES, 2016, 65 : A321 - A321
  • [44] Effects of Insulin Adherence and Delivery Device on Real World Outcomes Among Patients With Type 2 Diabetes Mellitus (T2DM)
    Ayyagari, Rajeev
    Wei, Wenhui
    Cheng, David
    Pan, Chunshen
    Wu, Eric Q.
    DIABETES, 2013, 62 : A327 - A327
  • [45] Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes
    Younossi, Zobair M.
    Gramlich, Terry
    Matteoni, Christi A.
    Boparai, Navdeep
    Mccullough, Arthur J.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2004, 2 (03) : 262 - 265
  • [46] ROLE OF PHARMACOTHERAPY IN REAL WORLD PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)
    Eghbali, Shabnam
    Newberry, Carolyn
    Yeung, Michele
    Sharaiha, Reem Z.
    Kumar, Sonal
    GASTROENTEROLOGY, 2021, 160 (06) : S839 - S839
  • [47] FOCUS ON THE TYPE 2 DIABETES PATIENT WITH LIVER DISEASE: EMPHASIS ON NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)
    Cusi, Kenneth
    ENDOCRINE PRACTICE, 2011, 17 : 9 - 13
  • [48] NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Bawany, Muhammad Adnan
    Lashari, Naveed Aslam
    Soomro, Majid Ali
    Memon, Hamid Nawaz Ali
    Laghari, Fiza
    Irshad, Muntaha
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 5 (07): : 6283 - 6286
  • [49] Pharmacogenomics and pharmacomicrobiomics in type 2 diabetes mellitus (T2DM)
    Luo, Jian-Quan
    Shu, Yan
    Zhang, Wei
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [50] Vascular responsiveness in type 2 diabetes mellitus (T2DM)
    Blum, A.
    Socea, D.
    Sirchan, R.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2016, 109 (12) : 791 - 796
12345